PBLA - Why Is Cancer Firm Panbela Therapeutics Stock Trading Higher Today? | Benzinga
Panbela Therapeutics Inc (NASDAQ: PBLA) shares are trading higher after the company announced the publication of preclinical and clinical data from studies of CPP-1X (also known as α-Difluoromethylornithine (DFMO) or Eflornithine) in recent-onset type 1 diabetes (T1D).
Data published in the journal Cell Reports Medicine investigated the mechanism of polyamines and polyamine inhibition by CPP-1X on β cell stress that plays a role in the onset of type 1 diabetes in in vitro and ex vivo models.
Results showed that DFMO treatment may preserve β ...